Investors Hangout Stock Message Boards Logo
  • Mailbox
  • Favorites
  • Boards
    • The Hangout
    • NASDAQ
    • NYSE
    • OTC Markets
    • All Boards
  • Whats Hot!
    • Recent Activity
    • Most Viewed Boards
    • Most Viewed Posts
    • Most Posted
    • Most Followed
    • Top Boards
    • Newest Boards
    • Newest Members
  • Blog
    • Recent Blog Posts
    • Recently Updated
    • News
    • Stocks
    • Crypto
    • Investing
    • Business
    • Markets
    • Economy
    • Real Estate
    • Personal Finance
  • Market Movers
  • Interactive Charts
  • Login - Join Now FREE!
  1. Home ›
  2. Stock Message Boards ›
  3. User Boards ›
  4. ALERTS, HOT STOCKS & CHARTS Message Board

Here's some information on CTIX which is a new and

Message Board Public Reply | Private Reply | Keep | Replies (0)                   Post New Msg
Edit Msg () | Previous | Next


Post# of 145218
Posted On: 10/25/2012 11:15:44 AM
Avatar
Posted By: Drano

Here's some information on CTIX which is a new and very active board here. I'm copying a post I put up on that board. So that you'll have a little background to understand the post, CTIX has a drug which in animal tests activated the p53 gene, which is a "cancer killer" gene whose malfunction is implicated in half or more cancers. Their drug Kevetrin activated this gene in animal models and had very strong cancer fighting efficacy. Here is more information on their OTHER drug:


For those who are new to CTIX, a unique feature of this company is that not only does it have a new approach to cancer treatment (Kevetrin, currently starting human trials), but as an "insurance policy" it has a second drug rapidly approaching human trials -- Prurisol. Prurisol is an effective treatment (I hesitate to say "cure" but it seems as if it might be) for psoriasis. Psoriasis is not only a common and uncomfortable, unsightly skin condition, but often is associated with a form of rheumatoid arthritis, psoriatic arthritis. Although the company has made NO claims in regards to other possible uses of Prurisol (should if prove effective in humans against psoriasis), we have speculated that if it is effective against an auto-immune disease like psoriasis, it might be effective against other auto-immune diseases as well. There are about 100 different syndromes lumped into the category of "rheumatoid arthritis" -- so perhaps those might be a target, as well as non-rheumatoid auto-immune diseases.


We have used the example of MDVN to illustrate the value of having a second drug in the pipeline as "insurance." When MDVN's flagship drug failed, its stock price was cut in half in a matter of minutes. Now, it is trading at 5 times those levels, because of the seeming success of another drug. It is quite amazing for a company the size of CTIX to have an "insurance policy" 2nd drug rapidly heading toward human trials, and there are other potential drugs in the company's intellectual property portfolio.


And many thanks to IH for hosting us. This is a great site.



(0)
(0)








Investors Hangout

Home

Mailbox

Message Boards

Favorites

Whats Hot

Blog

Settings

Privacy Policy

Terms and Conditions

Disclaimer

Contact Us

Whats Hot

Recent Activity

Most Viewed Boards

Most Viewed Posts

Most Posted Boards

Most Followed

Top Boards

Newest Boards

Newest Members

Investors Hangout Message Boards

Welcome To Investors Hangout

Stock Message Boards

American Stock Exchange (AMEX)

NASDAQ Stock Exchange (NASDAQ)

New York Stock Exchange (NYSE)

Penny Stocks - (OTC)

User Boards

The Hangout

Private

Global Markets

Australian Securities Exchange (ASX)

Euronext Amsterdam (AMS)

Euronext Brussels (BRU)

Euronext Lisbon (LIS)

Euronext Paris (PAR)

Foreign Exchange (FOREX)

Hong Kong Stock Exchange (HKEX)

London Stock Exchange (LSE)

Milan Stock Exchange (MLSE)

New Zealand Exchange (NZX)

Singapore Stock Exchange (SGX)

Toronto Stock Exchange (TSX)

Contact Investors Hangout

Email Us

Follow Investors Hangout

Twitter

YouTube

Facebook

Market Data powered by QuoteMedia. Copyright © 2025. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges).
Analyst Ratings & Earnings by Zacks. RT=Real-Time, EOD=End of Day, PD=Previous Day. Terms of Use.

© 2025 Copyright Investors Hangout, LLC All Rights Reserved.

Privacy Policy |Do Not Sell My Information | Terms & Conditions | Disclaimer | Help | Contact Us